
2026-04-09
Chithandizo cha khansa ya m'mapapo cha gawo loyamba mu 2026 chimayang'ana kwambiri pakuthandizira kuchiza, makamaka opaleshoni kapena stereotactic ablative radiotherapy (SABR), yomwe nthawi zambiri imalimbikitsidwa ndi perioperative immunotherapy kwa odwala oyenera. Ku China, zipatala zotsogola tsopano zimagwiritsa ntchito AJCC 9th edition staging system ndikupereka njira zotsogola zocheperako, zomwe mtengo wake umasiyana kwambiri pakati pa mabungwe aboma ndi apadera potengera zovuta za chisamaliro ndi kuyezetsa kwa maselo.
Malo a siteji yoyamba chithandizo cha khansa ya m'mapapo zasintha kwambiri pofika chaka cha 2026, kuchoka ku njira yopangira opaleshoni kupita ku njira yodziwika bwino kwambiri, yamitundu yosiyanasiyana. Khansara yoyambirira yosakhala yaying'ono ya m'mapapo ya m'mapapo (NSCLC), makamaka magawo 1 mpaka IIIB, tsopano ikuwonetsedwa kudzera m'maso mwamankhwala olondola. Cholinga chachikulu chimakhalabe kuchotsa chotupa chonse, koma njira zopezera izi ndi mankhwala othandizira ozungulira opaleshoni akhala ovuta kwambiri.
Malangizo apano akugogomezera kufunikira kwa masitepe olondola musanayambe kuchitapo kanthu. Kukhazikitsidwa kwa AJCC 9th edition TNM staging system kwawongolera momwe zotupa zimagawidwira m'magulu, kuwonetsetsa kuti odwala amalandira chithandizo choyenera kwambiri cha matenda awo enieni. Kulondola uku ndikofunikira chifukwa ngakhale mkati mwa gawo loyamba, pali kusiyana kwakukulu pakukula kwa chotupa ndi ma lymph node zomwe zimatsogolera njira yochizira.
Kwa odwala ambiri, ulendowu umayamba ndi kuzindikira kotsimikizika kotsatiridwa ndi kuwunika kwatsatanetsatane kwachilengedwe. Sitepe iyi sikhalanso yosankha; ndi muyezo wa chisamaliro. Kuyesa kwa EGFR, ALK, ndi PD-L1 mawu kumathandiza akatswiri a oncologists kudziwa ngati wodwala angapindule ndi chithandizo chomwe akufuna kapena immunotherapy, kaya asanachite opaleshoni kapena atatha. Njira yoyendetsedwa ndi datayi imatsimikizira izi siteji yoyamba chithandizo cha khansa ya m'mapapo si ndondomeko yofanana ndi imodzi koma ndondomeko yokonzedwa kuti iwonjezere kupulumuka ndi kuchepetsa kubwereza.
Opaleshoni ikadali mwala wapangodya wa cholinga chochizira gawo loyamba la NSCLC. Komabe, njira zopangira opaleshoni zomwe zidagwiritsidwa ntchito mu 2026 zidachoka kwambiri ku thoracotomy yachikhalidwe yotseguka. Muyezo wamakono wa chisamaliro umalimbikitsa kwambiri njira zochepetsera odwala popanda zotsutsana ndi anatomical.
Kusankha pakati pa VATS ndi opaleshoni ya robotic nthawi zambiri kumadalira luso la ochita opaleshoni komanso mawonekedwe enieni a chotupacho. Kwa zotupa zotumphukira zazing'ono kuposa ma centimita atatu okhala ndi ma lymph node a mediastinal, njira zowononga pang'ono ndi njira yoyamba yodzitetezera. Cholinga chake nthawi zonse ndi R0 resection, kutanthauza kuchotsedwa kwathunthu kwa chotupacho ndi malire omveka bwino.
Osati wodwala aliyense yemwe ali ndi khansa ya m'mapapo yoyamba ndi woyenera kuchitidwa opaleshoni. Zinthu monga ukalamba, kusagwira ntchito bwino kwa mapapu, kapena matenda ena owopsa angapangitse ngozi za opaleshoni kukhala zosavomerezeka. Kwa anthu awa, stereotactic ablative radiotherapy (SABR), yomwe imadziwikanso kuti SBRT, yatulukira ngati njira yothandiza kwambiri.
SABR imapereka milingo yayikulu ya radiation molondola kwambiri ku chotupacho ndikusunga minofu yathanzi yozungulira. Deta yaposachedwa ikuwonetsa kuti kwa odwala omwe sangagwire ntchito pachipatala, SABR ikhoza kupereka ziwongola dzanja zofananira ndi opaleshoni. Mu 2026, malangizo azachipatala amathandizira kugawana zisankho komwe odwala amadziwitsidwa kuti SABR ndi njira yabwino yochizira ngati opaleshoni sikutheka.
Kuphatikiza apo, kwa odwala ena omwe amatha kuchitidwa mwaukadaulo koma amakonda kupewa kuchitidwa opaleshoni, SABR ikukambidwa mokulira ngati njira ina kutsatira upangiri wokwanira. Ukadaulo wakumbuyo kwa SABR wayenda bwino, kulola kuwongolera koyenda bwino komanso kupenta kwa mlingo, komwe kumakulitsa mphamvu yake yolimbana ndi zotupa zam'mapapo zosuntha.
Chimodzi mwazofunikira kwambiri pakukula siteji yoyamba chithandizo cha khansa ya m'mapapo m'zaka zaposachedwa ndi kuphatikiza kwa immunotherapy mu perioperative setting. M'mbiri, chemotherapy inali chithandizo chokhazikika pambuyo pa opaleshoni kwa odwala omwe anali pachiwopsezo choyambirira. Komabe, paradigm yasintha ndikuyambitsa ma immune checkpoint inhibitors ngati pembrolizumab.
Kafukufuku wa KEYNOTE-671 wakhala wofunikira kwambiri pakukonzanso njira zachipatala. Mayesero odziwika bwinowa adawonetsa kuti kupereka pembrolizumab musanachite opaleshoni (neoadjuvant) komanso pambuyo pa opaleshoni (adjuvant), kuphatikiza ndi chemotherapy, kumathandizira kwambiri kupulumuka popanda zochitika. Pofika m'chaka cha 2026, zomwe zakhala zikuchitika kwa nthawi yayitali kuchokera ku phunziroli, ndi miyezi yopitilira 60 yotsatiridwa, zalimbitsa ntchito ya njirayi.
Kupeza kofunikira pakuwunika kwaposachedwa kwa mayeso a KEYNOTE-671 ndikuti odwala amapindula ndi perioperative immunotherapy mosasamala kanthu kuti apeza yankho lathunthu la pathological (pCR). pCR imatanthawuza kusakhalapo kwa ma cell chotupa otheka pachitsanzo cha opaleshoni pambuyo pa chithandizo cha neoadjuvant.
Deta iyi ikuwonetsa kuti kukhazikitsidwa kwa chitetezo chamthupi kumapereka chitetezo chokhazikika chomwe chimapitilira kuchepa kwa chotupacho. Zimatanthawuza kuti mayankho "ozama" a pathological amagwirizana ndi zotsatira zabwino, koma mlingo uliwonse wa chitetezo cha mthupi ndi wopindulitsa. Chifukwa chake, akatswiri a oncologists ku China komanso padziko lonse lapansi tsopano akuwunika pafupipafupi odwala omwe ali ndi gawo la II ndi IIIA panjira yophatikizika iyi.
Ngakhale kuti zopambana zoyamba zidawoneka mu matenda a siteji II ndi III, kupambana kwa perioperative immunotherapy kukupangitsa kuti afufuze momwe angathandizire odwala omwe ali pachiwopsezo chachikulu. Ngakhale kuti matenda amtundu wa IA nthawi zambiri amachiritsidwa ndi opaleshoni yokha, zotupa zazikulu za IB kapena omwe ali ndi chiopsezo chachikulu akuganiziridwa kuti ndi njira za neoadjuvant pamayesero azachipatala ndi malo apadera.
Cholinga chake ndi kuchiza matenda a micrometastatic msanga, chotupacho chisanachotsedwe, potero kuchepetsa mwayi wobwereza. Izi zikuyimira kusintha kwakukulu momwe timawonera khansa ya m'mapapo yoyambilira - osati ngati vuto lomwe liyenera kudulidwa, koma ngati matenda am'thupi omwe amafunikira kuwongolera mwadongosolo kuyambira pachiyambi.
Pofufuza siteji yoyamba chithandizo cha khansa ya m'mapapo ku China, odwala amatha kupeza zipatala zapamwamba kwambiri padziko lonse lapansi. Dzikoli lachita bwino kwambiri pakukhazikitsa chisamaliro chokhazikika komanso kutsatira malangizo apadziko lonse lapansi pomwe likugwiritsa ntchito kuchuluka kwa odwala poyendetsa kafukufuku ndi luso.
Kusankha chipatala choyenera ndikofunikira. Mabungwe apamwamba amadziwika ndi magulu awo osiyanasiyana (MDT), omwe amaphatikizapo opaleshoni ya thoracic, oncologists, akatswiri a radiation oncologists, radiologists, ndi akatswiri a zachipatala omwe amagwira ntchito limodzi kuti apange ndondomeko yabwino kwa wodwala aliyense. Malowa alinso patsogolo pakukhazikitsa gawo la AJCC 9th edition ndikuyesa mayeso oyenera a ma cell.
Ili ku Tianjin, bungweli ndi mtsogoleri wadziko lonse pa oncology. Motsogozedwa ndi akatswiri ngati Pulofesa You Jian, chipatalachi chathandizira kwambiri kutanthauzira ndikugwiritsa ntchito deta kuchokera ku mayesero akuluakulu apadziko lonse monga KEYNOTE-671. Dipatimenti yawo ya opaleshoni ya thoracic imadziwika chifukwa cha njira zochepetsera kwambiri komanso njira zolimba zosamalira odwala.
Chipatalachi chikugogomezera kufunikira kwa kuwunika kwa ma pathological ndi mbiri yama cell. Akhazikitsa mayendedwe okhwima kuti awonetsetse kuti wodwala aliyense wokhazikika wa NSCLC amawunikidwa kuti apeze phindu la immunotherapy. Zopereka zawo pa kafukufuku zimathandizira kufotokozera mulingo wa chisamaliro osati ku China kokha, komanso ku Asia konse.
Ku Hangzhou, Chipatala cha Khansa cha Zhejiang, motsogozedwa ndi akatswiri monga Pulofesa Xu Yujin, ndi chida china chothandizira chithandizo cha khansa ya m'mapapo. Chipatalachi chimadziwika chifukwa chophatikiza ukadaulo wapamwamba kwambiri pakuzindikira komanso kuchiza. Amatenga nawo mbali m'mayesero azachipatala padziko lonse lapansi, kupatsa odwala mwayi wopeza chithandizo chatsopano asanapezeke kwambiri.
Njira yawo yopangira khansa ya m'mapapo imakhudza kusamalidwa koyenera, kuphatikiza kusanja kwapakati pakafunika. Amagwiritsa ntchito njira zamakono zojambulira ndi kufufuza kothandizidwa ndi AI kuti azindikire kukhudzidwa kwa nodal komwe kungathe kuphonya kwina, kuonetsetsa kuti ndondomeko ya chithandizo ikugwirizana bwino ndi gawo la matenda.
Kuchokera ku Guangzhou, chipatalachi chimapereka chisamaliro chokwanira ndikuyang'ana kwambiri njira zothandizira payekha. Pulofesa Cheng Chao ndi gulu lake adadzipereka kuti akwaniritse njira zochiritsira. Amakhala aluso kwambiri pakuwongolera milandu yovuta yomwe ma comorbidities amatha kusokoneza njira zachipatala.
Bungweli likugogomezera kwambiri maphunziro a odwala ndikugawana zisankho. Amawonetsetsa kuti odwala amamvetsetsa zovuta za matenda awo, zifukwa zomwe amasankha opaleshoni motsutsana ndi SABR, komanso mapindu omwe angapezeke pakuwonjezera chitetezo chamthupi. Chitsanzo cha odwala ichi chikugwirizana ndi zochitika zapadziko lonse za chithandizo chamankhwala chofunikira.
Masitepe olondola ndiye maziko ogwira mtima siteji yoyamba chithandizo cha khansa ya m'mapapo. Kusazindikira kungayambitse kusamalidwa bwino kapena kuwopsa kosafunika. Mu 2026, zipatala zaku China zimatsata njira zowunikira kuti zitsimikizire kulondola.
Kusintha kupita ku AJCC 9th edition TNM staging system kwabweretsa magulu ochulukirapo. Kusintha uku kumakonza matanthauzo a magulu a kukula kwa chotupa ndi ma lymph node station. Mwachitsanzo, kusiyana pakati pa zotupa za T1a, T1b, ndi T1c tsopano ndizofunikira kwambiri pozindikira kukula kwa opaleshoni komanso kufunika kwa chithandizo chamankhwala.
Zipatala ku China zasintha machitidwe awo operekera malipoti kuti agwirizane ndi miyezo yatsopanoyi. Izi zimatsimikizira kugwirizana kwa kulankhulana pakati pa madokotala ndikuthandizira kulembetsa molondola m'mayesero achipatala. Zimathandiziranso kulosera kwabwinoko, kuthandiza odwala ndi madokotala kukhazikitsa ziyembekezo zenizeni.
Anapita masiku omwe kuyezetsa kwa biomarker kudasungidwira matenda apamwamba. Malangizo apano alamula kuti odwala onse omwe ali ndi NSCLC yokhazikika ayesedwe madalaivala ofunikira. Izi zikuphatikiza kusintha kwa EGFR, kukonzanso kwa ALK, ndi mafotokozedwe a PD-L1.
Kuyesa kwathunthuku tsopano ndi chizolowezi m'zipatala zapamwamba zaku China. Nthawi yosinthira zotsatira yatsika chifukwa cha kukonza kwanyumba zopangira ma labotale, zomwe zimapangitsa kuti chithandizo chiyambe popanda kuchedwa kosafunika.
Kujambula kokhako nthawi zina sikukwanira kuthetsa ma lymph node metastasis. Kwa odwala ambiri omwe ali ndi matenda amtundu wa I ndi II, makamaka omwe ali ndi zotupa zapakati kapena zokayikitsa pa CT/PET scans, invasive mediastinal staging ikulimbikitsidwa musanachite opaleshoni.
Njira monga Endobronchial Ultrasound (EBUS) ndi Endoscopic Ultrasound (EUS) zimagwiritsidwa ntchito kwambiri. Njira zowononga pang'ono izi zimalola kuti pakhale biopsy yeniyeni ya mediastinal lymph nodes. Ngati matenda a N2 atsimikiziridwa, dongosolo la chithandizo limachoka ku opaleshoni yam'tsogolo kupita ku neoadjuvant therapy, makamaka kusintha njira ya wodwalayo.
Kumvetsetsa gawo lazachuma la siteji yoyamba chithandizo cha khansa ya m'mapapo ndizofunikira kwa odwala omwe akukonzekera chisamaliro chawo ku China. Mitengo imatha kusiyanasiyana kutengera gawo lachipatala, chithandizo chamankhwala chofunikira, komanso momwe wodwalayo alili.
Mtengo wonse wa chithandizo umaphatikizapo zigawo zingapo: kuwunika kwa matenda, opaleshoni kapena ma radiation, ma pathology, kuyezetsa ma cell, ndi njira zochiritsira zilizonse.
Dongosolo la inshuwaransi yachipatala yaku China limakhudza gawo lalikulu lamankhwala okhazikika. Opaleshoni, chemotherapy wamba, ndi ma radiotherapy oyambira nthawi zambiri amakhala ophimbidwa bwino. Komabe, chithandizo chamankhwala atsopano monga immunotherapy ndi opaleshoni ya robotic zimasiyana malinga ndi dera komanso ndondomeko ya inshuwalansi.
M'zaka zaposachedwa, mankhwala ambiri amakono, kuphatikiza ma immunotherapies ofunikira, adaphatikizidwa mu National Reimbursement Drug List (NRDL). Izi zachepetsa kwambiri ndalama zotuluka m'thumba kwa odwala. Mwachitsanzo, pembrolizumab ndi zoletsa zina za PD-1 tsopano ndi zobwezeredwa pang'ono pazowonetsa zinazake, zomwe zimapangitsa kuti azifikirika ndi anthu ambiri.
Odwala akulangizidwa kukaonana ndi ofesi ya inshuwaransi ya chipatala poyambirira. Zipatala zina zimaperekanso mgwirizano wa inshuwaransi yazamalonda kapena mapulogalamu othandizira kuti athandizire kuthetsa kusiyana kwamankhwala okwera mtengo omwe salipiridwa mokwanira ndi inshuwaransi yoyambira.
Kwa odwala ochokera kumayiko ena kapena akunyumba omwe akufuna chithandizo, kuyendetsa njira zachipatala kungakhale kovuta. Njira yokhazikika imatsimikizira kuti palibe njira zovuta zomwe zaphonya komanso kuti wodwalayo alandire bwino siteji yoyamba chithandizo cha khansa ya m'mapapo.
Kutsatira izi kumapereka mphamvu kwa odwala kutenga nawo mbali pa chisamaliro chawo. Imawonetsetsanso kulumikizana ndi malangizo aposachedwa a 2026, kukulitsa mwayi wochiritsidwa.
Pofuna kuthandiza odwala ndi mabanja kumvetsetsa zomwe angasankhe, tebulo lotsatirali likufanizira njira zoyambira zothandizira khansa ya m'mapapo mu 2026.
| Chithandizo cha Makhalidwe | Makhalidwe Ofunikira | Mbiri Yabwino Yosankhidwa |
|---|---|---|
| Opaleshoni Yochepa Kwambiri (VATS/Robotic) | Muyezo wagolide wochizira; amachotsa chotupa ndi mfundo; amafuna mankhwala ambiri; kuchira kwakanthawi. | Odwala omwe ali ndi zotupa zotupa; okondedwa kwa zotumphukira ndi chapakati siteji I zotupa. |
| Stereotactic ablative Radiotherapy (SABR) | Zosasokoneza; mkulu mlingo mwatsatanetsatane cheza; palibe chiopsezo cha opaleshoni; ndondomeko ya outpatient. | Odwala osagwira ntchito kuchipatala; amene akukana opaleshoni; zotupa zazing'ono zotumphukira. |
| Perioperative Immunotherapy + Chemo | Zokhudza zonse mankhwala isanayambe kapena itatha mankhwala m`deralo; amachepetsa chiopsezo chobwereza; imathandizira ma micrometastases. | Resectable Stage II-IIIA (ndi kusankha IB omwe ali pachiwopsezo chachikulu); odwala omwe ali ndi machitidwe abwino. |
| Tsegulani Thoracotomy | Traditional lalikulu incision; kupweteka kwakukulu ndi nthawi yochira; kugwiritsidwa ntchito ngati kusokoneza pang'ono sikutheka. | Zotupa zovuta zomwe zimafuna kukonzanso kwakukulu; odwala ndi wandiweyani adhesions kuchokera opaleshoni isanayambe. |
Kuyerekeza uku kukuwonetsa kuti ngakhale opaleshoni ikadali njira yayikulu yochizira, nkhani yomwe imaperekedwa yasintha. Kuwonjezeredwa kwamankhwala amtundu uliwonse komanso kupezeka kwa njira zina zowongoleredwa zapamwamba kwambiri zimapereka chitetezo pazosowa zosiyanasiyana za odwala.
Kuyang'ana kupitilira 2026, gawo la chithandizo cha khansa ya m'mapapo likupitilirabe kupanga. Zosintha zingapo zomwe zikubwera zikuyembekezeka kuwonjezeredwa siteji yoyamba chithandizo cha khansa ya m'mapapo ndi kuwonjezera zotsatira.
Ma algorithms a AI akukhala ofunikira pakuwunika ntchito. Zida zimenezi zimatha kusanthula ma CT scan molondola kwambiri kuposa anthu, kuzindikira tinthu tambirimbiri tosaoneka bwino komanso kuzindikira ma lymph nodes omwe maso a munthu angaphonye. Ku China, "China Protocol" yoyezetsa khansa ya m'mapapo imagwiritsa ntchito AI kupititsa patsogolo kuchuluka kwa anthu omwe azindikira msanga, ndikupangitsa kuti kuchuluka kwa matenda omwe ndimapeza kumakwera.
AI imathandizanso pokonzekera mankhwala podziwiratu kuti ndi odwala ati omwe angayankhepo pa mankhwala enaake. Kuthekera kodziwiratu kumeneku kumasunthira mankhwala kufupi ndi makonda enieni, kumachepetsa kuyeserera ndi zolakwika.
Kuyesa kwa chotupa cha DNA (ctDNA) kapena madzi a biopsy, kukukula ngati chida chowunika momwe chithandizo chimayankhira ndikuzindikira matenda otsalira ochepa (MRD). Pambuyo pa opaleshoni, kuyezetsa kwabwino kwa ctDNA kungasonyeze maselo a khansa otsala, zomwe zimapangitsa kuti alowererepo ndi chithandizo cha adjuvant.
Njira yosasokoneza iyi imapereka mawonekedwe osinthika a momwe matendawa alili, zomwe zimalola madokotala kuti asinthe mapulani amankhwala munthawi yeniyeni. Pamene ukadaulo umakhala wovuta komanso wotsika mtengo, ukuyembekezeka kukhala gawo lokhazikika pakuwunika pambuyo pa opaleshoni.
Pamene chiwongola dzanja chikuwonjezeka, cholinga chake chikusunthira ku moyo wabwino kwa opulumuka. Mapulogalamu okhudzana ndi kuteteza chonde, kuyang'anira thanzi la mtima, ndi chithandizo chamaganizo akuphatikizidwa mu ndondomeko za chithandizo. Pozindikira kuti khansa yayamba kutha kwa anthu ambiri, zipatala zikugwiritsa ntchito njira yosamalira anthu onse.
Kusinthaku kumavomereza kuti kuchiza matendawa ndi gawo chabe la ntchito; kuthandiza odwala kubwerera ku moyo wokhutiritsa n'kofunika mofanana. Ntchito zothandizira zothandizira zikukula kuti zikwaniritse zosowa za "sandwich generation" ya odwala omwe amalinganiza chithandizo ndi ntchito ndi mabanja.
Inde, khansa ya m'mapapo ya gawo loyamba ndi yochiritsika kwambiri. Ndi chithandizo choyenera, monga opaleshoni kapena SABR, kupulumuka kwazaka zisanu kwa matenda a IA kumatha kupitirira 90%. Chinsinsi chake ndikuzindikira msanga ndikutsata ndondomeko zovomerezeka zachipatala.
Nthawi imasiyanasiyana malinga ndi nthawi. Opaleshoni nthawi zambiri imaphatikizapo kukhala m'chipatala masiku atatu mpaka 7, ndikuchira kwathunthu kumatenga milungu ingapo mpaka miyezi. Ngati perioperative immunotherapy iwonjezeredwa, njira yonse ya chithandizo, kuphatikizapo magawo oyambirira ndi pambuyo pa opaleshoni, amatha miyezi 6 mpaka 12. SABR nthawi zambiri imamalizidwa mu magawo 1 mpaka 5 pa sabata imodzi kapena ziwiri.
Pakadali pano, perioperative immunotherapy ndiyokhazikika pagawo II ndi IIIA rectable NSCLC. Kwa matenda a siteji I, nthawi zambiri samawonetsedwa pokhapokha ngati pali zoopsa kapena kulembetsa ku mayeso azachipatala. Komabe, malangizo amasintha mwachangu, chifukwa chake kukambirana nkhani yanu ndi oncologist ndikofunikira.
Opaleshoni imakhala ndi zoopsa monga matenda, kutuluka magazi, ndi kupweteka, ngakhale kuti njira zochepetsera pang'ono zimachepetsa izi. Immunotherapy imatha kuyambitsa zovuta zokhudzana ndi chitetezo chamthupi zomwe zimakhudza mapapu, khungu, kapena matumbo. SABR ikhoza kuyambitsa kutopa kapena kutupa komweko. Mavuto ambiri amatha kutha ndi kuyang'aniridwa ndi achipatala.
Chaka cha 2026 ndi nthawi ya mwayi womwe sunachitikepo kwa odwala omwe ali ndi siteji yoyamba chithandizo cha khansa ya m'mapapo. Kupita patsogolo kwa njira zopangira opaleshoni, kuphatikizika kwa perioperative immunotherapy, komanso kulondola kwa matenda amakono asintha momwe khansa ya m'mapapo imayambira. Ku China, zipatala zapamwamba kwambiri padziko lonse lapansi zikutsogola, zopereka chisamaliro chomwe chimapikisana kwambiri padziko lonse lapansi.
Kuchita bwino pochiza khansa ya m'mapapo kumadalira kuphatikizika kwa nthawi yake, masitepe olondola, komanso mwayi wopeza ukatswiri wosiyanasiyana. Odwala amalimbikitsidwa kuti akapeze chithandizo ku zipatala zapadera komwe malangizo aposachedwa amatsatiridwa mosamalitsa. Kaya kudzera mu maopaleshoni ang'onoang'ono, ma radiation apamwamba, kapena kaphatikizidwe ka mankhwala, cholinga chake ndi chodziwikiratu: kuchiritsa ndi kubwerera ku moyo wapamwamba.
Kuyenda ulendowu kumafuna zisankho zodziwitsidwa. Pomvetsetsa zomwe zilipo, kufunikira kwa kuyesa kwa biomarker, ndi mapindu omwe angakhalepo a mankhwala atsopano, odwala akhoza kulimbikitsa chisamaliro chabwino kwambiri. Tsogolo la chithandizo cha khansa ya m'mapapo ndi lowala, motsogozedwa ndi sayansi komanso kudzipereka pakusamalidwa koyenera kwa odwala.